Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Research ArticleTools for Practice

Topical management of tinea pedis

Betsy Thomas, Jamison Falk and G. Michael Allan
Canadian Family Physician January 2021; 67 (1) 30; DOI: https://doi.org/10.46747/cfp.670130
Betsy Thomas
Clinical Evidence Expert at the College of Family Physicians of Canada.
BScPharm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamison Falk
Associate Professor in the College of Pharmacy at the University of Manitoba in Winnipeg.
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Michael Allan
Director of Programs and Practice Support at the College of Family Physicians of Canada.
MD CCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Clinical question

How effective are topical treatments for tinea pedis?

Bottom line

Tinea pedis is successfully treated with topical antifungals in 70% to 75% of patients compared with 20% to 30% using placebo. Tea tree oil is likely ineffective. Topical terbinafine might result in an absolute improvement of 2% to 8% more patients cured over other topicals. Most patients were treated for 1 week with terbinafine and 4 to 6 weeks with azoles (like clotrimazole).

Evidence

Results are statistically significant unless indicated.

  • Studies comparing with placebo found the following.

    • - Systematic review (67 RCTs) of mycologically diagnosed tinea pedis (and oncychomycosis, not included here), reporting laboratory-confirmed treatment failure at 6 weeks.1

      • — Allylamines (eg, terbinafine, naftifine), 9 RCTs (N = 876), 1 to 4 (most 4) weeks’ treatment: 25% versus 80% placebo; number needed to treat (NNT) of 2.

      • — Azoles (eg, clotrimazole, miconazole), 6 RCTs (N = 448), 4 to 6 weeks’ treatment: 28% versus 70% placebo; NNT = 3.

      • — Tea tree oil, 1 RCT (N = 71), 4 weeks’ treatment: no difference from placebo.

    • - Systematic review of topical terbinafine versus placebo, 9 RCTs (N = 986), 1 to 4 (1 most common) weeks’ treatment2: clinical cure, 72% terbinafine versus 28% placebo; NNT = 3.

      • — Other systematic reviews found similar results.3-5

  • Direct comparisons found the following.

    • - Allylamines versus azoles.

      • — Systematic review, 8 RCTs (N = 1034), 1 to 6 (most 1 to 2) weeks’ treatment3: mycological cure, 78% allylamines versus 76% azoles; NNT = 40.

    • - Topical terbinafine versus other antifungals.

      • — Systematic review, 10 RCTs (N = 1341), 1 to 4 (most 1) weeks’ treatment2: clinical cure, 83% terbinafine versus 75% other antifungals (statistical significance reported inconsistently; if real, NNT = 13).

  • Adverse events: burning, stinging, and itching sensations were most common (but not quantified).1

  • Limitations: some RCTs1 and 1 systematic review2 were industry funded; clinical cure is less commonly reported than mycological cure.

Context

  • Topical antifungals are suggested as first-line agents, reserving oral agents for severe disease (eg, moccasin-type infection), failed topical treatment, and immunocompromised patients.6

  • Approximate cost (for 30 g)7-9:

    • - 1% clotrimazole cream, twice daily, $13,

    • - 2% miconazole cream, twice daily, $15, and

    • - 1% terbinafine cream, twice daily, $30.

Implementation

It is uncertain whether foot hygiene or changing footwear is beneficial; however, placebo arms from RCTs suggest it might help.4 The Centers for Disease Control and Prevention advise that patients with tinea pedis keep feet dry, clean, and cool; wear sandals, if possible (especially in locker rooms); air out shoes; and wear cotton socks.10 Patients can discuss over-the-counter options with their pharmacists, such as clotrimazole or miconazole, although these tend to require a longer treatment duration. Nystatin should not be used owing to dermatophyte resistance.6 Terbinafine cream, twice a day for 7 days, is a reasonable prescription option with a short treatment duration and well supported efficacy.

Notes

Tools for Practice articles in Canadian Family Physician are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in Canadian Family Physician are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to toolsforpractice{at}cfpc.ca. Archived articles are available on the ACFP website: www.acfp.ca.

Footnotes

  • Competing interests

    None declared

  • The opinions expressed in Tools for Practice articles are those of the authors and do not necessarily mirror the perspective and policy of the Alberta College of Family Physicians.

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Crawford F,
    2. Hollis S.
    Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2007;(3):CD001434.
  2. 2.↵
    1. Korting HC,
    2. Kiencke P,
    3. Nelles S,
    4. Rychlick R.
    Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis. Am J Clin Dermatol 2007;8(6):357-64.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Rotta I,
    2. Otuki MF,
    3. Sanches AC,
    4. Correr CJ.
    Efficacy of topical antifungal drugs in different dermatomycoses: a systematic review with meta-analysis. Rev Assoc Med Bras (1992) 2012;58(3):308-18.
    OpenUrlPubMed
  4. 4.↵
    1. Crawford F.
    Athlete’s foot. BMJ Clin Evid 2009;2009:1712.
    OpenUrl
  5. 5.↵
    1. Rotta I,
    2. Sanchez A,
    3. Gonçalves PR,
    4. Otuki MF,
    5. Correr CJ.
    Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. Br J Dermatol 2012;166(5):927-33.
    OpenUrlPubMed
  6. 6.↵
    1. Ely JW,
    2. Rosenfeld S,
    3. Seabury Stone M.
    Diagnosis and management of tinea infections. Am Fam Physician 2014;90(10):702-10.
    OpenUrlPubMed
  7. 7.↵
    Interactive drug benefit list. Alberta Health; 2020. Available from: https://idbl.ab.bluecross.ca/idbl/load.do. Accessed 2020 Mar 21.
  8. 8.
    Micatin cream 2% - miconazole nitrate cream USP, 30 g. Mississauga, ON: Walmart Corporation; 2020. Available from: https://www.walmart.ca/en/ip/micatin-cream-2-miconzole-nitrate-cream-usp-30-g/6000189068419. Accessed 2020 Jul 13.
  9. 9.↵
    Canesten 1% topical antifungal cream. Mississauga, ON: Walmart Corporation; 2020. Available from: https://www.walmart.ca/en/ip/bayer-healthcare-consumer-care-canesten-1-topical-antifungal-cream/6000017348217. Accessed 2020 Jul 13.
  10. 10.↵
    Hygiene-related disease. Athlete’s foot (tinea pedis). Bethesda, MD: Centers for Disease Control and Prevention; 2017. Available from: https://www.cdc.gov/healthywater/hygiene/disease/athletes_foot.html. Accessed 2020 Oct 26.
PreviousNext
Back to top

In this issue

Canadian Family Physician: 67 (1)
Canadian Family Physician
Vol. 67, Issue 1
1 Jan 2021
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Topical management of tinea pedis
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Topical management of tinea pedis
Betsy Thomas, Jamison Falk, G. Michael Allan
Canadian Family Physician Jan 2021, 67 (1) 30; DOI: 10.46747/cfp.670130

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Topical management of tinea pedis
Betsy Thomas, Jamison Falk, G. Michael Allan
Canadian Family Physician Jan 2021, 67 (1) 30; DOI: 10.46747/cfp.670130
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Clinical question
    • Bottom line
    • Evidence
    • Context
    • Implementation
    • Notes
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Testosterone supplementation for men
  • Time to challenge penicillin allergy labels
  • Antibiotics for acute diverticulitis
Show more Tools for Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire